Table 1.
Infection Phase | Clinical Presentation | Treatment Approach | Sources |
Viral replication | Upper respiratory tract infection, fever, muscle fatigue, pain | Antiviral agents are used to decrease viral load, transmission, and prevent progression to the next phases of the disease | [10,11,12] |
Immune hyperactivation | Dyspnea, pneumonia, vasculopathy, acute cardiac and renal damage, sepsis, secondary infections |
Monoclonal antibodies, anti-coagulants, immunosuppressants, oxygen, antiviral drugs | |
Post-Acute Sequelae of COVID-19 | Fatigue, headache, dyspnea, and anosmia | Immunosuppressants, convalescent plasma therapy | [13,14,15] |